BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 25160235)

  • 1. A novel SVM-ID3 hybrid feature selection method to build a disease model for melanoma using integrated genotyping and phenotype data from dbGaP.
    Son YA; Yücebaş SC
    Stud Health Technol Inform; 2014; 205():501-5. PubMed ID: 25160235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prostate cancer model build by a novel SVM-ID3 hybrid feature selection method using both genotyping and phenotype data from dbGaP.
    Yücebaş SC; Aydın Son Y
    PLoS One; 2014; 9(3):e91404. PubMed ID: 24651484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inherited genetic variants associated with occurrence of multiple primary melanoma.
    Gibbs DC; Orlow I; Kanetsky PA; Luo L; Kricker A; Armstrong BK; Anton-Culver H; Gruber SB; Marrett LD; Gallagher RP; Zanetti R; Rosso S; Dwyer T; Sharma A; La Pilla E; From L; Busam KJ; Cust AE; Ollila DW; Begg CB; Berwick M; Thomas NE;
    Cancer Epidemiol Biomarkers Prev; 2015 Jun; 24(6):992-7. PubMed ID: 25837821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melanoma risk prediction using a multilocus genetic risk score in the Women's Health Initiative cohort.
    Cho HG; Ransohoff KJ; Yang L; Hedlin H; Assimes T; Han J; Stefanick M; Tang JY; Sarin KY
    J Am Acad Dermatol; 2018 Jul; 79(1):36-41.e10. PubMed ID: 29499294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association of host and genetic melanoma risk factors with Breslow thickness in the Western Australian Melanoma Health Study.
    Cadby G; Ward SV; Cole JM; Moses EK; Millward M; Palmer LJ
    Br J Dermatol; 2014 Apr; 170(4):851-7. PubMed ID: 24405011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Replication of associations between GWAS SNPs and melanoma risk in the Population Architecture Using Genomics and Epidemiology (PAGE) Study.
    Kocarnik JM; Park SL; Han J; Dumitrescu L; Cheng I; Wilkens LR; Schumacher FR; Kolonel L; Carlson CS; Crawford DC; Goodloe RJ; Dilks H; Baker P; Richardson D; Ambite JL; Song F; Quresh AA; Zhang M; Duggan D; Hutter C; Hindorff LA; Bush WS; Kooperberg C; Le Marchand L; Peters U
    J Invest Dermatol; 2014 Jul; 134(7):2049-2052. PubMed ID: 24480881
    [No Abstract]   [Full Text] [Related]  

  • 7. Pigmentation-related genes and their implication in malignant melanoma susceptibility.
    Fernandez LP; Milne RL; Pita G; Floristan U; Sendagorta E; Feito M; Avilés JA; Martin-Gonzalez M; Lázaro P; Benítez J; Ribas G
    Exp Dermatol; 2009 Jul; 18(7):634-42. PubMed ID: 19320733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A genetic algorithm-support vector machine method with parameter optimization for selecting the tag SNPs.
    Ilhan I; Tezel G
    J Biomed Inform; 2013 Apr; 46(2):328-40. PubMed ID: 23262450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting the disease of Alzheimer with SNP biomarkers and clinical data using data mining classification approach: decision tree.
    Erdoğan O; Aydin Son Y
    Stud Health Technol Inform; 2014; 205():511-5. PubMed ID: 25160237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics of malignant melanoma.
    Laporte M
    Acta Chir Belg; 1998 Jun; 98(3):139-40. PubMed ID: 9689976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The susceptibility CDKN2 locus may have a role on prognosis of melanoma patients.
    Casula M; Budroni M; Cossu A; Ascierto PA; Mozzillo N; Canzanella S; Muggiano A; Palmieri G
    Ann Oncol; 2010 Jun; 21(6):1379-1380. PubMed ID: 20231302
    [No Abstract]   [Full Text] [Related]  

  • 12. A support vector machine for decision support in melanoma recognition.
    Gilmore S; Hofmann-Wellenhof R; Soyer HP
    Exp Dermatol; 2010 Sep; 19(9):830-5. PubMed ID: 20629732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel multiplex pyrosequencing assay for genotyping functionally relevant CTLA-4 polymorphisms: potential applications in autoimmunity and cancer.
    Banelli B; Morabito A; Laurent S; Piccioli P; Dozin B; Ghio M; Ascierto PA; Monteghirfo S; Marasco A; Ottaviano V; Queirolo P; Romani M; Pistillo MP
    Hum Immunol; 2014 Aug; 75(8):730-9. PubMed ID: 24801647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SNP selection and classification of genome-wide SNP data using stratified sampling random forests.
    Wu Q; Ye Y; Liu Y; Ng MK
    IEEE Trans Nanobioscience; 2012 Sep; 11(3):216-27. PubMed ID: 22987127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IRF4 SNP is predictive of melanoma subtypes.
    Granovetter M
    Lancet Oncol; 2016 Mar; 17(3):e96. PubMed ID: 26907189
    [No Abstract]   [Full Text] [Related]  

  • 16. Mining susceptibility gene modules and disease risk genes from SNP data by combining network topological properties with support vector regression.
    Hua L; Zhou P; Liu H; Li L; Yang Z; Liu ZC
    J Theor Biol; 2011 Nov; 289():225-36. PubMed ID: 21910999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translating genome wide association study results to associations among common diseases: in silico study with an electronic medical record.
    Anand V; Rosenman MB; Downs SM
    Int J Med Inform; 2013 Sep; 82(9):864-74. PubMed ID: 23743324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation of malignant melanoma from benign nevus using a novel genomic microarray with low specimen requirements.
    Chandler WM; Rowe LR; Florell SR; Jahromi MS; Schiffman JD; South ST
    Arch Pathol Lab Med; 2012 Aug; 136(8):947-55. PubMed ID: 22849744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Childhood melanoma: what every pediatrician should know.
    Dinulos J
    Curr Opin Pediatr; 2009 Aug; 21(4):472-4. PubMed ID: 19617832
    [No Abstract]   [Full Text] [Related]  

  • 20. Progress report on the major clinical advances in patient-oriented research into familial melanoma (2013-2018).
    Visser M; van der Stoep N; Gruis N
    Fam Cancer; 2019 Apr; 18(2):267-271. PubMed ID: 30659395
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.